Corporate Reputation of Global Pharma Companies, 2021-2022: How do Pharma Companies Rank Two years into Covid
January 09, 2023 07:13 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Global Edition" report has been added to ResearchAndMarkets.com's offering. ...
Corporate Reputation of Pharma Companies in 2021-2022: The Patient Perspective of 520 Cancer Patient Groups - Pfizer Ranked 1st, Roche/Genentech Ranked 2nd and Novartis was 3rd
January 05, 2023 05:53 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been added...
Corporate Reputation of the Pharma Companies 2021-2022 Based on 168 HIV/AIDS Patient Groups: AbbVie, BMS, Gilead Sciences, GSK, Janssen, Merck, Mylan, Roche/Genentech, Sandoz, Sanofi, Teva, ViiV
December 13, 2022 05:28 ET
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups" report has been...
The Corporate Reputation of Pharma in 2021-2022: The Views of 303 Rare-Disease Patient Groups on 32 Pharma Companies
December 09, 2022 07:18 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups" report has...
UK Patient's Perspective on the Corporate Reputation of Pharma, 2021-2022: The Views of 111 Patients Groups Two Years into COVID-19
December 09, 2022 07:13 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 Patient Groups" report has been added to ...